Breaking News: A New Era for Non-Invasive Tests to Detect Liver Fibrosis & Identify Patients for Novel Therapies

We're tackling a rapidly evolving landscape of MASH. With new therapies now available for non-cirrhotic MASH with significant fibrosis, accurate patient stratification is essential. Noninvasive testing (NIT) has proven to be a highly accurate and practical tool for detecting significant liver fibrosis. This engaging session highlights the urgent unmet needs in MASH management and reviews the latest clinical data on breakthrough treatments. The live exchange between experts will dive into the practical, clinical utility of NITs for accurately assessing liver fibrosis.

• CE: 1.5 CME Hours
• Supported by: Siemens Healthineers
• Organized by: Medscape Education
• For more information and to register, visit: http://www.medscape.org/sympo/nits-in-mash